Granules India acquires Senn Chemicals AG to expand peptide therapeutics and CDMO capabilities Read more
Budget expectations: Leaders opine for incentives in the nutra and API manufacturing sectors Read more
Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets Read more
Granules India’s Gagillapur facility classified as “Official Action Indicated” following US FDA Inspection Read more
